- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Dr. Archana Hingorani has completed her five-year term as an Independent Director at Alembic Pharmaceuticals, effective February 3, 2025. The Board has expressed gratitude for her contributions during her tenure. This transition may prompt a review of board composition and governance structures, impacting company strategy and investor confidence. While the departure of an experienced director poses some risk, it also opens opportunities for fresh perspectives in leadership. Investors might view this as a neutral impact, pending the appointment of a suitable successor to bolster the board's expertise.